Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study

Authors:

Abstract
Objective: To evaluate the effect of topical ophthalmic 0.005% latanoprost alone and in combination with 0.1% diclofenac on healthy horses.Animals studied: Twelve healthy adult horses.Procedures: A randomized, masked crossover design was used with horses divided into three groups for once daily treatment in one randomly selected eye. For arm 1 of the study, Group D (n= 3) received 0.1% diclofenac, Group L (n= 3) received 0.005% latanoprost, and GroupDL(n= 6) received 0.005% latanoprost and 0.2 ml of 0.1% diclofenac. For arm 2 of the study, horses from Group D and L were placed into GroupDLand horses from GroupDLwere placed into either Group D or L. Evaluations of intraocular pressure (IOP), vertical pupil diameter, aqueous flare, conjunctival hyperemia, epiphora, blepharospasm, and blepharoedema were performed 4 times daily on days 1 and 2 (baseline), days 3 to 7 (arm 1 treatment), days 8 to 11 (washout), days 12 to 16 (arm 2 treatment), and days 17 and 18 (return to baseline).Results: During the treatment period, significant reduction inIOPand vertical pupil diameter occurred in treated eyes of Groups L andDL, but not Group D. These variables did not differ significantly between Groups L andDL. Blepharospasm, blepharoedema, epiphora, and conjunctival hyperemia scores were significantly higher in Group L than in Groups D andDL.Conclusions: Latanoprost reducedIOPin healthy horses and signs of drug‐induced discomfort were mitigated by concurrent use of diclofenac.

This publication has 27 references indexed in Scilit: